The expanding role of BAP1 in clear cell renal cell carcinoma

被引：12
|
作者：
Kapur, Payal [1 ,2 ,3 ,6 ]
Rajaram, Satwik [1 ,4 ]
Brugarolas, James [3 ,5 ]
机构：
[1] Univ Texas Southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr, Dept Urol, Dallas, TX 75390 USA
[3] Simmons Comprehens Canc Ctr, Kidney Canc Program, Dallas, TX 75390 USA
[4] Univ Texas Southwestern Med Ctr, Lyda Hill Dept Bioinformat, Dallas, TX 75390 USA
[5] Univ Texas Southwestern Med Ctr, Dept Internal Med Hematol Oncol, Dallas, TX 75390 USA
[6] Univ Texas Southwestern Med Ctr, Dept Pathol, Kidney Canc Program, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
来源：
HUMAN PATHOLOGY | 2023年 / 133卷
关键词：
BAP1; ccRCC; RCC; PBRM1; TUMOR-SUPPRESSOR; BRCA1-ASSOCIATED PROTEIN-1; MUTATIONS PREDISPOSE; PBRM1; OUTCOMES; SETD2; VHL; INACTIVATION; ACTIVATION; EXPRESSION;
D O I：
10.1016/j.humpath.2022.07.022
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Mutations drive renal cell carcinoma biology and tumor growth. The BRCA1-associated protein-1 (BAP1) gene is frequently mutated in clear cell renal cell carcinoma (ccRCC) and has emerged as a prognostic and putative predictive biomarker. In this review, we discuss the role of BAP1 as a signature event of a subtype of ccRCC marked by aggressiveness, inflammation, and possibly a heightened response to immunotherapy. (c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码：22 / 31
页数：10
相关论文
共 50 条
  • [1] Expression of Bap1 in Clear Cell Renal Cell Carcinoma
    Fatima, Arooj
    JOURNAL OF PATHOLOGY, 2024, 264 : S12 - S12
  • [2] BAP1 LOSS IS ASSOCIATED WITH METASTASIS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA
    Khaleel, Sari
    Reiner, Anne
    Brennan, Cameron
    Hussain, Ibrahim
    Berman, Samuel
    Hakimi, Ari
    Moss, Nelson
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1018 - E1018
  • [3] BAP1 Loss Defines a Pathologically Aggressive Subgroup of Clear Cell Renal Cell Carcinoma
    Kapur, P.
    Christie, A.
    Pena-Llopis, S.
    Margulis, V.
    Lotan, Y.
    Xie, X-J
    Brugarolas, J.
    LABORATORY INVESTIGATION, 2013, 93 : 223A - 223A
  • [4] Report Clear cell renal cell carcinoma with BAP1 mutation: a report of two cases
    Lee, Jennifer
    Thuzar, Moe
    DiPoto-Brahmbhatt, Angela C.
    Chaudoir, Catherine
    Tanner, Anthony
    Fazili, Tajammul
    Yu, Xiuping
    Constantinescu, Michael
    Yeh, Y. Albert
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2023, 11 (05): : 429 - 434
  • [5] The immune characteristic analysis of BAP1 mutated clear cell renal cell carcinoma.
    Wang, Zilin
    Liang, Jiayu
    Zeng, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 466 - 466
  • [6] Advancements in Radiogenomics for Clear Cell Renal Cell Carcinoma: Understanding the Impact of BAP1 Mutation
    Greco, Federico
    D'Andrea, Valerio
    Buoso, Andrea
    Cea, Laura
    Bernetti, Caterina
    Zobel, Bruno Beomonte
    Mallio, Carlo Augusto
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [7] Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression
    Joseph, Richard W.
    Kapur, Payal
    Serie, Daniel J.
    Parasramka, Mansi
    Ho, Thai H.
    Cheville, John C.
    Frenkel, Eugene
    Parker, Alexander S.
    Brugarolas, James
    JOURNAL OF UROLOGY, 2016, 195 (01): : 180 - 187
  • [8] BAP1 Loss Results in mTORC1 Activation in Clear Cell Renal Cell Carcinoma
    Kapur, P.
    Christie, A.
    Pena-Llopis, S.
    Margulis, V.
    Lotan, Y.
    Xie, X-J
    Brugarolas, J.
    MODERN PATHOLOGY, 2013, 26 : 223A - 223A
  • [9] BAP1 Loss Defines a Pathologically Aggressive Subgroup of Clear Cell Renal Cell Carcinoma
    Kapur, P.
    Christie, A.
    Pena-Llopis, S.
    Margulis, V.
    Lotan, V.
    Xie, X-J
    Brugarolas, J.
    MODERN PATHOLOGY, 2013, 26 : 223A - 223A
  • [10] BAP1 Loss Results in mTORC1 Activation in Clear Cell Renal Cell Carcinoma
    Kapur, P.
    Christie, A.
    Pena-Llopis, S.
    Margulis, V.
    Lotan, Y.
    Xie, X-J
    Brugarolas, J.
    LABORATORY INVESTIGATION, 2013, 93 : 223A - 223A
12345